Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,390,788
+$1,060,091 QoQ
Shares Held
2,827
+11.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#2,021
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CALTON & ASSOCIATES, INC. holds $9,328,876 across 9 Drug Manufacturers - General names. LLY ranks #1 (36.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,827 | $3,390,788 | |
| 2 | JNJ |
Johnson & Johnson
|
6,320 | $1,605,090 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,693 | $1,245,550 | |
| 4 | ABBV |
AbbVie Inc.
|
4,822 | $1,213,408 | |
| 5 | PFE |
Pfizer Inc
|
26,875 | $647,150 | |
| 6 | AMGN |
Amgen Inc
|
1,111 | $402,315 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,244 | $302,159 | |
| 8 | GSK |
GSK plc
|
5,418 | $284,011 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,390,788 | 2,827 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,330,697 | 2,534 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,006,954 | 2,798 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,332,491 | 3,057 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,724,320 | 2,212 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,091,204 | 2,532 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $780,492 | 1,011 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,626,585 | 1,836 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $937,068 | 1,035 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $802,076 | 1,031 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $753,132 | 1,292 | Shares | Sole | 2024-02-07 | |
| 2023-06-30 | $619,053 | 1,320 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $408,326 | 1,189 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $721,436 | 1,972 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $570,066 | 1,763 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $571,617 | 1,763 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $578,181 | 2,019 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $579,233 | 2,097 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $573,697 | 2,483 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $617,179 | 2,689 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $502,172 | 2,688 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $519,014 | 3,074 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $465,374 | 3,144 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $488,107 | 2,973 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $441,961 | 3,186 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||